Publications

Sep 19, 2022

Anti-cancer activity of ST101, a novel antagonist of CCAAT/enhancer binding protein β

Molecular Cancer Therapeutics, a journal of the American Association for Cancer Research, September 19, 2022 (online)

May 14, 2020

Constitutive Expression of the Immunosuppressive Tryptophan Dioxygenase TDO2 in Glioblastoma Is Driven by the Transcription Factor C/EBPβ

Frontiers in Immunology

Dec 23, 2009

The transcriptional network for mesenchymal transformation of brain tumors

Nature

Sep 1, 2008

Translationally regulated C/EBP beta isoform expression upregulates metastatic genes in hormone-independent prostate cancer cells

Prostate

Mar 1, 2006

Increased expression of CCAAT/enhancer binding protein ß correlates with prognosis in glioma patients

Oncology Reports